Convenios - Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud

¡Buenas noticias para Bogotá y toda Colombia! El Banco Distrital de Sangre del IDCBIS ha obtenido la certificación más prestigiosa en calidad para los bancos de sangre a nivel internacional. La Fundación CAT, reconocida entidad de certificación en transfusión, terapia celular y tisular de España, ha otorgado a esta institución de salud una acreditación que garantiza la excelencia en sus prestaciones médicas.

Este logro trascendental coloca al Banco Distrital de Sangre IDCBIS en un lugar destacado no solo a nivel nacional, sino también como referente internacional en bancos de sangre y servicios de transfusión. Nuestra entidad ha demostrado su compromiso inquebrantable con la calidad y la seguridad al ser el único banco en el país que realiza pruebas de biología molecular (NAT) al 100% de los componentes sanguíneos para garantizar la seguridad en las transfusiones.

La acreditación CAT, que se renueva cada cuatro años, destaca la excelencia en medicina transfusional que el Banco Distrital de Sangre IDCBIS ofrece a la sociedad. Tanto los donantes como los pacientes que reciben los hemocomponentes de este banco se benefician de la seguridad y calidad garantizada por esta certificación.

El Dr. Bernardo Camacho, director del IDCBIS, expresó su satisfacción al recibir la noticia: “Nos complace anunciar a la comunidad científica, académica, sanitaria y a la sociedad, la obtención de esta certificación internacional en calidad para nuestro Banco Distrital de Sangre. Cumplimos con los más altos estándares de calidad europeos en la captación, procesamiento y distribución de los hemocomponentes”.

Esta certificación no solo enaltece al Banco Distrital de Sangre IDCBIS, sino que también posiciona a Bogotá como un referente en calidad en medicina transfusional, generando reconocimiento y confianza en los productos y servicios de salud ofrecidos a la población. El compromiso de nuestra institución con la seguridad y calidad de las donaciones es evidente en sus estrictos protocolos y estándares internacionales, lo que garantiza que cada donante experimente un proceso seguro y cómodo.

Le puede interesar: Una donación, cuatro bebés beneficiados

Con este logro, los pacientes que dependen de transfusiones sanguíneas pueden tener la tranquilidad de recibir componentes de la más alta calidad y seguridad.

En resumen, el Banco Distrital de Sangre IDCBIS ha alcanzado un hito excepcional al obtener la certificación CAT, consolidando su liderazgo en la medicina transfusional y proyectando a Bogotá como una ciudad comprometida con la excelencia en el cuidado de la salud de sus ciudadanos. Esta noticia nos llena de orgullo y confianza en el sistema de salud de nuestra ciudad y país.

¡Felicidades al Banco Distrital de Sangre IDCBIS por este logro sobresaliente en beneficio de toda la comunidad!

The District Tissue Bank of the District Institute of Science, Biotechnology and Innovation in Health (IDCBIS) has established itself as a reference bank in Latin America, training health professionals from different countries of the continent, this time the turn was for Chile.

August 26, 2022. The tissue bank of Iquique, Chile, is developing a project that arises from the need of skin allografts for the management of burn patients. In Chile, on average there is only one skin donor in the country per year, therefore, the availability of cadaveric donor skin for transplantation is almost null. This opened the need for the use of living donor skin from body contouring surgeries.

In order to improve, grow and have the standards that a tissue bank requires, doctors Aldo Cañete, children's surgeon and director of the Regional Skin and Tissue Bank; Luana Mandriaza, coordinator of the Regional Bank; Jennifer Gómez, nurse in charge of organ and tissue procurement; María José Pulgar, nurse coordinator of the skin program and Dr. Marcelo Fonseca, plastic surgeon, arrived in Bogotá on August. Marcelo Fonseca, plastic surgeon, arrived in Bogota on August 22 and during their visit they have been trained in the processes of rescue, processing and quality management of lamellar tissue, skin, amniotic membrane and acellular dermis at the IDCBIS District Tissue Bank.

During their visit, the professionals of the Tissue Bank of Iquique attended the Burn Unit of the Simon Bolivar Hospital, as a referral in the integral treatment of the burned patient.

The District Tissue Bank of the District Institute of Science, Biotechnology and Innovation in Health (IDCBIS) is the only multipurpose public bank in the country and the first in Latin America with development and standardization in acellular dermis to favor the regeneration of definitive skin in burn patients. The Bank has INVIMA certification in good practices for ocular, musculoskeletal and skin tissue, in addition to being pioneers in Colombia in the amniotic membrane donation program, tissue that is used for the treatment of burn patients and for ophthalmology and maxillofacial surgery specialties.

"This knowledge that IDCBIS has given us will help our patients in Chile, since we are the only ones who process skin and we will be able to perfect our processes to improve the quality of life of many people," said Dr. Marcelo Fonseca, plastic surgeon.

This referral visit was possible thanks to the willingness of the Bank's staff headed by the director of IDCBIS, Dr. Bernardo Camacho, who has been leading international cooperation agreements that allow the consolidation of a scientific and medical community in the country and the region around research and altruism of citizenship.

The District Tissue Bank IDCBIS will donate the skin to attend burn patients in the Mantanzas region of Cuba.

August 19, 2022. On August 5, in the province of Matanzas, Cuba, a fire broke out in an industrial zone due to a lightning strike in an oil storage facility, which caused the conflagration, leaving more than 60 people injured with burns.

The District Tissue Bank IDCBIS, an entity linked to the District Health Secretariat, as humanitarian aid has donated 3 thousand cm2 of skin to the Cuban Government to help in the recovery of the wounded from the massive fire that occurred in this country.

The donation was made thanks to the efforts of the Colombian Ministry of Health in alliance with the Cuban Vice-Ministry of Health, the Cuban Ambassador to Colombia and the District Institute of Science, Biotechnology and Innovation in Health (IDCBIS) linked to the District Health Secretariat of Bogota.

The Director of IDCBIS, Bernardo Camacho, stated that "in addition to expressing the generosity and international solidarity of this donation with the tragedy, it is the recognition of the high quality and trust in the IDCBIS District Tissue Bank to distribute to burn patients who need this tissue for their recovery. These tissues were rescued from Colombian donors, complying with all safety and quality standards for the care of patients who require it."

The IDCBIS currently has the only multipurpose Tissue Bank in the country, which favors access to the most vulnerable population with transplant requirements and has the selection of donors, rescue, processing, preservation, storage and distribution of human tissues with high quality standards. It is the only multipurpose bank in the country and the first in Latin America with development and standardization in acellular dermis to improve the regeneration of definitive skin in burn patients.

The Bank processes cornea and sclera, skin, musculoskeletal tissue and amniotic membrane for use in ophthalmology, plastic surgery and maxillofacial surgery.

Media coverage

Telesur: Colombia donates skin for burned patients of the fire in Cuba

Infobae: Colombia to donate 3,000 centimeters of skin to Cuba as part of humanitarian aid for the emergency in Matanzas

El Colombiano: Colombia joins humanitarian aid to Cuba: will donate skin for the injured in Matanzas

galardonado con la ORDEN CIVIL AL MÉRITO Dona Bogotá 2017-2018-2019 About the District Tissue Bank

The District strengthens health research with the cooperation agreement between the Universidad Nacional de Colombia - Bogotá and the Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud.

Seminar on Health Research 2022: dialogues between research, academia and institutions to make visible, relate, recognize and establish possible strategic alliances around health research.

August 9, 2022. The agreement between the two institutions has a duration of 5 years and seeks to create a framework for scientific cooperation to advance joint actions in the areas of training, research, extension, technical, administrative and academic assistance, which allow the institutional strengthening of both entities. After only seven months of having started to implement the agreement, 3 projects have already been submitted to calls for proposals from the Ministry of Science, Technology and Innovation - Minciencias.

The National University of Colombia - Bogotá campus is a national leader in higher education and research according to the U-Sapiens Ranking, recognized for its contribution to the nation and for its excellence in training, research, and social and technological innovation processes.

For its part, IDCBIS has established itself as an institution of reference in the country, achieving recognition as a research center by the Ministry of Science, Technology and Innovation under Resolution 1763 of 2021, demonstrating the ability of IDCBIS to generate high impact products, relevant to the scientific and academic society, and to society in general.

An important point of this agreement is the development of the 2022 Health Research Seminar, which opened the door for all those interested to access spaces led by experts, with the participation of 37 researchers and the attendance of more than 900 people in the five cycles.

Topics related to the health area were discussed, such as: predictive and personalized medicine, cellular therapies, neurodegenerative and rheumatologic diseases, population genetics and social appropriation of knowledge.

This space was an opportunity to establish dialogues between research, academia and institutions, contributing to the objective of making visible, relating, recognizing and establishing possible strategic alliances.

About IDCBIS:

The District Institute of Science, Biotechnology and Innovation in Health is a research center linked to the Health Sector of the Capital District. It promotes the advancement of health sciences, biotechnological research, the provision of biological supplies and the training of human resources in transfusion medicine, advanced tissue and cellular therapy and engineering, regenerative medicine and laboratory medicine.

Statement 1.

Call for Financial Support for Doctoral Student Related to Hematopoietic Progenitor Cell Donation and Transplantation in Colombia

View press release here

investigadores-la-universidad-miami-idcbis-firman-convenio-cientifico-1200x600.jpg

A group of prestigious researchers from the University of Miami and the Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud (IDCBIS), of the Mayor's Office of Bogota, are working together on the treatment of type I diabetes in Colombia.

Camillo Ricordi, Director of the Diabetes Research Institute; Diego Correa, Assistant Professor at the Miller School of Medicine of the University of Miami; Bernardo Camacho, Director of IDCBIS and Luis Gonzalo Morales Sánchez, Secretary of Health, met in the country's capital to exchange knowledge and experiences on the treatment of the disease.

"These prestigious scientists will share with us successful techniques and technologies for the transplantation of pancreatic islets in Type I Diabetes; what we are looking for is that patients, especially children and adolescents are not dependent on insulin and have a better quality of life," explained Bernardo Camacho, director of the IDCBIS.

In the last decade, important clinical evidence has been generated that shows the safety and efficacy of this treatment based on cell therapy, especially from the experience of the Diabetes Research Institute (DRI) of the Miller School of Medicine of the University of Miami. This group, led by Dr. Camllo Ricordi, has been the world pioneer in pancreatic islet transplantation, with more than 25 years of experience in the application of this procedure.

Pancreatic Islet Transplantation can be improved ostensibly with the help of other therapies, on which the Cell Therapy Unit of IDCBIS is working.

colombia-se-beneficiara-de-trasplantes-de-celulas-madre-01-1200x600.png

Research generated with resources from the General System of Royalties in Science, Technology and Innovation.

We would like to inform the public that this morning the project "Research oriented to the implementation of best practices for the clinical application of cellular therapies. Model: TPH in Bogota"was unanimously approved by the Collegiate Administrative and Decision Making Body - OCAD for Science, Technology and Innovation for a total amount of $12.530.211.296 financed by the General Royalties System.

This project presented by the District Health Financial Fund and formulated by the District Institute of Science, Biotechnology and Innovation in Health - IDCBIS in association with the HOMI Foundation will benefit patients who are candidates for progenitor stem cell transplants, thus continuing to strengthen the Science, Technology and Innovation system in the area of regenerative medicine.

This project is articulated with projects previously approved by the General Royalties System in 2012 and 2016: "Implementation of the public cord blood bank and cell therapy unit at Hemocentro, Bogotá." y “Estudios técnicos para la implementación del registro nacional de donantes de progenitores hematopoyéticos” taking into account that the model for the application of good clinical practices for cell therapy will be the Progenitor Stem Cell Transplantation.

Until the implementation of these projects, the alternatives of access to the search for compatible donors of umbilical cord blood, bone marrow or peripheral blood units mobilized in Colombia were made only through international registries. In Colombia, the Transplantation of Progenitor Stem Cells from blood of the Public Bank started this year with units that come from a genetically similar Colombian donor, but not a family member.

This project is important for Colombia because it has become a pole of development of these therapies due to its research and innovative approach in biotechnology for the service of public health, reducing social inequality in a transnational context.

Formulating group:

Dr. Bernardo Camacho - @B_CamachoMD

Dr. Ana María Perdomo

Dr. Gustavo Salguero

Dra. Jenny Ríos

Public Cord Blood Bank

Cell Therapy Unit

Executing Entity

District Health Financial Fund

Find out all the details of the project approval:

Through this agreement, IDCBIS and Universidad del Rosario will join efforts to promote the exchange of experiences in the fields of research, extension, innovation, management and technology transfer, within the various areas of knowledge that each entity manages.

The agreement will strengthen research fields such as:

-Transfusion and transplantation medicine

- Advanced cellular and tissue engineering and therapy

-Regenerative medicine.

In this way, it is hoped to promote cooperation in scientific and technological initiatives that can create solid knowledge networks.

Blog

Banco Distrital de Sangre IDCBIS de Bogotá Certificado con los Más Altos Estándares de Calidad Europeos

The District Tissue Bank of Bogota receives a referral visit from the Tissue Bank of Iquique, Chile.

Donation of 3 thousand cm2 of skin as humanitarian aid from Colombia to burn victims in Matanzas, Cuba.

The District strengthens health research with the cooperation agreement between the Universidad Nacional de Colombia - Bogotá and the Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud.

Announcement 1. Call for Support for PhD Students

Researchers from the University of Miami, Lili Valley Foundation, The Pro Cure Diabetes Healing Foundation and IDCBIS carry out scientific collaboration for the treatment of type I diabetes.

Colombia will benefit from stem cell transplants from Colombian donors.

Signing of the SAP-9765 agreement between IDCBIS and Universidad del Rosario.

Primera patente concedida al IDCBIS en el uso de células mesenquimales

Bogotá da un paso adelante de mano de la ciencia y la investigación con el proyecto pionero en salud “Donantes Únicos”

¿Por qué son tan importantes las donaciones O- en este momento?

¿Cómo surgieron los bancos de sangre?

IDCBIS

BANCO DISTRITAL DE SANGRE

Instalaciones:

Phone:

PASIÓN POR LA CIENCIA Y LA VIDA